Gilead Sciences (GILD) Total Debt (2009 - 2026)

Gilead Sciences (GILD) has reported Total Debt for 18 consecutive years, with $22.2 billion the latest figure, recorded in Q1 2026.

• Total Debt for Q1 2026 came in at $22.2 billion, down 11.13% year-over-year; the trailing twelve-month figure through Mar 2026 was $22.2 billion (down 11.13% YoY), and the FY2025 annual result was $24.9 billion, down 6.65% from the prior year.
• Total Debt was $22.2 billion for Q1 2026 at Gilead Sciences, down from $24.9 billion in the prior quarter.
• Over five years, Total Debt peaked at $26.7 billion in Q4 2024 and troughed at $22.2 billion in Q1 2026.
• Average Total Debt over 5 years is $24.9 billion, with a median of $25.0 billion recorded in 2023.
• Year-over-year, Total Debt declined 13.12% in 2022 and climbed 7.28% in 2025.
• Over 5 years, Total Debt stood at $25.2 billion in 2022, then decreased by 0.96% to $25.0 billion in 2023, then rose by 6.9% to $26.7 billion in 2024, then retreated by 6.65% to $24.9 billion in 2025, then decreased by 11.08% to $22.2 billion in 2026.
• Per Business Quant data, the three most recent Total Debt figures were $22.2 billion in Q1 2026, $24.9 billion in Q4 2025, and $24.9 billion in Q3 2025.